Tevimbra 2L ESCC Launch Meeting

The Tevimbra 2L ESCC Launch Meeting, held in Hong Kong, marked a significant milestone in advancing treatment options for ESCC patients. This hybrid conference brought together 60 distinguished oncologists from Hong Kong, Mainland China, and South Korea, with an additional 30 physicians participating via live streaming from Macau. The event was meticulously designed to foster collaboration and knowledge exchange, reflecting the commitment of BeiGene to enhance oncology care.

To create an engaging atmosphere, the event featured a pre-event backdrop with a photobooth, allowing participants to capture and print memorable moments. The thematic decor, including several backdrops and lightboxes, emphasized the event's mission: spreading hope to ESCC patients through the introduction of Tevimbra, a cost-effective treatment option in Hong Kong’s medical landscape.

A striking 7m x 3.5m video wall served as the centerpiece for visual presentations, complemented by two additional projector side displays. This impressive setup was achieved within a tight timeframe, showcasing our team’s efficiency and dedication. The lighting system created an inviting ambiance, while the AV system, equipped with a soundbar and stage panel, ensured clear and impactful communication throughout the event.

The highlight of the launch was the ceremonial unveiling of Tevimbra, featuring a hot air balloon on stage. This symbolic gesture, animated to rise into the sky following a kickoff by C-suite executives and esteemed oncologists, illustrated the collective aspiration to uplift local cancer patients and journey together toward new horizons.

In conclusion, the Tevimbra 2L ESCC Launch Meeting not only successfully introduced a pivotal treatment option but also fostered a sense of community among healthcare professionals, reinforcing BeiGene's role as a leader in oncology innovation.